Company Filing History:
Years Active: 2020-2023
Title: Innovations by Eun Hye Jung
Introduction
Eun Hye Jung is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of pharmaceuticals, holding a total of four patents. Her work focuses on developing compounds that have potential therapeutic applications.
Latest Patents
One of her latest patents involves pyrrolidine and piperidine compounds. This technology provides these compounds or their pharmaceutically acceptable salts, along with preparation processes, pharmaceutical compositions, and their uses. Notably, these compounds may be applied in the treatment and prevention of FAP-mediated diseases. Another significant patent includes aryl or heteroaryl triazolone derivatives or their salts. This technology also encompasses preparation processes and pharmaceutical compositions. The derivatives exhibit selective inhibitory activity on VAP-1, making them useful for treating nonalcoholic hepatosteatosis (NASH).
Career Highlights
Eun Hye Jung is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. Her innovative work has positioned her as a key figure in the development of new therapeutic agents.
Collaborations
She collaborates with talented coworkers, including Na Ry Ha and Tae Dong Han, contributing to a dynamic research environment.
Conclusion
Eun Hye Jung's contributions to pharmaceutical innovations highlight her expertise and commitment to advancing medical science. Her patents reflect her dedication to developing effective treatments for various diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.